Background Cell-based regenerative medicine therapies are now frequently tested in
clinical trials. In many conditions, cell therapies are administered systemically, but there is …

Regenerative medicine therapies hold enormous potential for a variety of currently incurable
conditions with high unmet clinical need. Most progress in this field to date has been …

Mesenchymal stem/stromal cells (MSCs) present a promising tool in cell-based therapy for
treatment of various diseases. Currently, optimization of treatment protocols in clinical …

Recently, mesenchymal stem cells (MSCs) are increasingly used as a panacea for multiple
types of disease short of effective treatment. Dozens of clinical trials published demonstrated …

The incidence of end stage kidney disease is rising annually and it is now a global public
health problem. Current treatment options are dialysis or renal transplantation, which apart …

Due to their multi/pluripotency and immunosuppressive properties, mesenchymal
stem/stromal cells (MSCs) are important tools for treatment of immune disorders and tissue …

Stem cell based-therapies are novel therapeutic strategies that hold key for developing new
treatments for diseases conditions with very few or no cures. Although there has been an …

Cell-based therapies have been making great advances toward clinical reality. Despite the
increase in trial activity, few therapies have successfully navigated late-phase clinical trials …

Mesenchymal stem/stromal cells (MSCs) are a promising resource for cell-based therapy
because of their high immunomodulation ability, tropism towards inflamed and injured …

Abstract Background Mesenchymal stromal cells (MSCs) offer great potential for diverse
clinical applications. However, conventional systemic infusion of MSCs limits their …